BioSpace News Archive

PharmaCyte is a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®

The Quebec – Clinical Research Organization in Cancer (Q-CROC) and the Oncopole are proud to announce the creation of a partnership to support clinical research in oncology.

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology company, announced today that it filed an Investigational New Drug Application (IND) with the FDA to move forward a radiotherapeutic drug, CTT1403, into human clinical trials for prostate cancer.

MedAfford Global Inc. (MGI), an international discount brand-name medication facilitator, makes it even easier and more accessible for U.S. consumers to save up to 80% off the cost of retail brand-name medications any time of the day by pricing and ordering online through MedAfford Global Inc.'s 24/7 secure website.

130 patients treated with Agenus’ PD-1 & CTLA-4; clinical benefit >63% treated

FSD Pharma Inc. announced today that its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”) received a positive International Search Authority (ISA) report from the Patent Cooperation Treaty (PCT) for its SCN-001 cannabidiol (CBD) combination therapy, the basis of its “Steady Stomach” product.

Ra Pharmaceuticals, Inc. today announced that senior management will present at the following upcoming investor conferences

Q1'19 revenue of $551.8 million increased 1% as-reported, or 3% in constant currency, from the prior-year period.

Centene Corporation announced today it will present at two upcoming healthcare conferences this month.

Cirius Therapeutics today announced the presentation of two posters further describing the activity of MSDC-0602K in diet-induced models of non-alcoholic steatohepatitis (NASH).